BEAT - HeartBeam and Triple Ring Technologies to co-develop telehealth solution device

HeartBeam (NASDAQ:BEAT) has signed a professional services agreement with Triple Ring Technologies, a co-development company, to assist in the design and development of its Telehealth complete solution 3D vector Electrocardiogram collection device for remote heart attack or myocardial infarction monitoring. The joint partnership is a five-phase expedited device development project scheduled to be completed in Q4 2022 for a 510k submission to the FDA. “The joint effort will be a five-phase expedited device development project to rapidly build and test our 3D vector collection device. Patients place this credit card sized device on their chest for a 30 second signal ECG recording, capturing the heart’s electrical activity from three angles in 3D by recording 3 (xyz) projections of the heart vector. A smartphone application connected to the device communicates with the HeartBeam cloud for a diagnostic suggestion and synthesized 12-lead ECG overlaid with baseline. A physician can then remotely view the results

For further details see:

HeartBeam and Triple Ring Technologies to co-develop telehealth solution device